Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to prevent and treat breast cancer. Its lead drug candidate under development is oral (Z)-endoxifen, which it is developing for both the prevention and treatment of breast cancer. (Z)-endoxifen is the potent Selective Estrogen Receptor Modulator for estrogen receptor inhibition and causes estrogen receptor degradation. In addition to its potent anti-estrogen effects, (Z)-endoxifen has been shown to target PKCB1, a known oncogenic protein, at clinically attainable blood concentrations. We show 31 historical shares outstanding datapoints in our ATOS shares outstanding history coverage, used to compute ATOS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ATOS market cap history over the course of time is important for investors
interested in comparing ATOS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ATOS versus a peer is one thing; comparing
ATOS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ATOS can fluctuate over the course of history.
With this page we aim to empower investors researching ATOS by allowing them to research the ATOS market cap history. |
Free ATOS Email Alerts:
Video: The Importance of Market Cap
